Worth Asset Management’s Novo Nordisk NVO Stock Holding History

Worth Asset Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,340	Closed	-$108K	–	300
2023 Q2	$108K	Buy	1,340 +720	+116%	+$58.8K	0.08%	132
2023 Q1	$49.3K	Hold	620	–	–	0.04%	182
2022 Q4	$42K	Hold	620	–	–	0.03%	199
2022 Q3	$31K	Hold	620	–	–	0.02%	190
2022 Q2	$35K	Hold	620	–	–	0.02%	237
2022 Q1	$32K	Buy	+620	New	+$31.8K	0.02%	258

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Worth Asset Management's NVO Position: Q3 2023 in Review

Worth Asset Management sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 1,340 shares — an estimated $108K sold.

Worth Asset Management first reported a position in NVO in Q1 2022 and held it in 6 quarters. The position peaked at $108K in Q2 2023. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

Worth Asset Management reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
Worth Asset Management sold 1,340 Novo Nordisk shares in Q3 2023, an estimated $108K.
Worth Asset Management first reported a position in Novo Nordisk in Q1 2022 and held it in 6 quarters.
Worth Asset Management's Novo Nordisk position peaked at $108K in Q2 2023.
1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.